Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
InduPro, Inc. closes $77 million Series B financing to support Phase 1 clinical development of IDP-001 for cancer treatment.
PRIVATEAug 12, 2026•about 3 hours ago
Amount Raised
$77 Million
Round Type
Series B
SeattleBiotechnologyHealth CareTherapeutics
Description
InduPro, Inc. announced the closing of a $77 million Series B financing. The financing will support the Phase 1 clinical development of the company's lead oncology program IDP-001. They have also dosed the first patient in the study
Company Information
Company
InduPro
Location
Seattle, Washington, United States
About
InduPro, Inc. is a biotechnology company that defines protein spatial relationships to create novel therapeutics for the treatment of cancer and autoimmune diseases. They target cell surface proteins in a variety of disease contexts by leveraging inherent or induced protein proximity. Their approach relies on a unique discovery engine (ProXiMATE) to generate potential first-in-class and best-in-class novel therapeutic candidates across multiple indications and modalities.
Related People
Suggested for you
1 contact
Verified contactsNo contacts on file at InduPro yet.
SeattleBiotechnologyHealth CareTherapeutics